Real-time enrollment status for this epidermolysis bullosa, dystrophic clinical trial
Current Status
Recruiting
Checked: November 15, 2026 at 2:54 PM UTC
| NCT Number | NCT06423573 |
| Recruiting Status | Recruiting |
| Condition | Epidermolysis Bullosa, Dystrophic |
| Phase | Clinical Trial |
| Target Enrollment | 170 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Chiesi Farmaceutici S.p.A. |
| Last Updated on CT.gov | September 28, 2026 (Sep 28, 2026) |
As of November 15, 2026: Clinical trial NCT06423573 is currently recruiting participants. This clinical trial study for epidermolysis bullosa, dystrophic is actively seeking new participants at 6 locations across the United States. The study is sponsored by Chiesi Farmaceutici S.p.A.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06423573 is actively recruiting participants as of November 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06423573 was last updated Sep 28, 2026 (September 28, 2026). HelloStudys verifies this status automatically.